Evidence map›Paper›PMID 12633669›Full record

ReviewCurrent opinion in immunology2003

Class-switch recombination: after the dawn of AID.

Amy L Kenter

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in immunology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Regulation of B-cell function by NF-kappaB c-Rel in health and disease.Cellular and molecular life sciences : CMLS · 2020
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Class switch recombination in selective IgA-deficient subjects.Clinical and experimental immunology · 2006
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Novel antibody switching defects in human patients.The Journal of clinical investigation · 2003
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Amy L KenterDepartment of Microbiology and Immunology, University of Illinois College of Medicine, 835 South Wolcott Avenue, Chicago, IL 60680, USA. star1@uic.edu
University of Illinois Urbana-Champaign · US

Funding

Factors and DNA Motifs Involved in Ig Class SwitchR01AI052400 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KENTER, AMY L · 2003 to 2012
$3.7M
CHARACTERIZING ISOTYPE SWITCHING USING SWITCH SUBSTRATESR01AI045045 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KENTER, AMY L. · 2000 to 2003
$1.1M
NIAID NIH HHS R01 AI045045NIAID NIH HHS R01 AI052400NIAID NIH HHS R01 AI 45045
6 · The paper itself

Abstract

Isotype class switching is central to the humoral immune response. The discovery that mutations in the activation-induced deaminase (AID) gene inhibit class-switch recombination, somatic hypermutation and gene conversion is a major step forward in defining the underlying mechanisms of these gene modification events. The propensity of mutations to occur at dC/dG nucleotides during somatic hypermutation and the homology between AID and cytidine deaminase has resulted in studies demonstrating that AID has the properties of a cytidine-specific mutator and also that elements of the base-excision repair pathway play a central role in class switching and hypermutation. AID is not a promiscuous mutator in the B cell, suggesting that there are specific molecular targeting mechanisms that regulate the accessibility of DNA to AID and differentially regulate class-switch recombination and somatic hypermutation. During class switching, isotype-specific targeting occurs independently of AID and provides another level of specificity to this recombination event.

Indexed as

AICDA (Activation-Induced Cytidine Deaminase)AnimalsCytidine DeaminaseDNADNA RepairGene ConversionGenes, ImmunoglobulinHumansImmunoglobulin Class SwitchingModels, GeneticMutationAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseDNA

Identifiers

PMID12633669
PMCPMC4975044
OpenAlexW2094097491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.